Systematic (IUPAC) name | |
---|---|
(6R,7R)-7-{[(2R)-2-amino-2-(1-cyclohexa-1,4- dienyl)acetyl]amino}-3-methyl-8-oxo-5-thia- 1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a601206 |
Pregnancy cat. | ? |
Legal status | ℞ Prescription only |
Routes | Oral, IM, IV |
Pharmacokinetic data | |
Bioavailability | Well absorbed |
Protein binding | <10% |
Metabolism | Nil |
Half-life | 0.9 hours |
Excretion | Renal, unchanged |
Identifiers | |
CAS number | 38821-53-3 |
ATC code | J01DB09 |
PubChem | CID 38103 |
DrugBank | DB01333 |
ChemSpider | 34933 |
UNII | 9YA6SX5S4D |
KEGG | D00264 |
ChEBI | CHEBI:3547 |
ChEMBL | CHEMBL1604 |
Chemical data | |
Formula | C16H19N3O4S |
Mol. mass | 349.406 g/mol |
SMILES | eMolecules & PubChem |
|
|
(verify) |
(what is this?)
Cefradine (INN) (formerly cephradine BAN) is a first generation cephalosporin antibiotic.
It has similar spectrum of activity to cefalexin.
Capsules containing 250 mg or 500 mg, Syrup containing 250 mg/5 ml, or vials for injection containing 500 mg or 1 g.